Abstract
Introduction:

50
The gastrointestinal tract is resident to over 300 different species of bacteria 1 . The 51 process of their bacterial adhesion has two-phases which are comprised of an initial, 52 instantaneous, and reversible physical phase followed by a time-dependent and 53 irreversible molecular and cellular phase 2 . It is well recognized that the adhesion of 54 bacteria to biological surfaces is a prerequisite to invasion and is the first step in 55 pathogenesis 3 . After attachment, in most cases pathogens will penetrate the 56 epithelial layer, interacting with leukocytes and macrophages to induce an immune 57 response. Bacterial adherence is also an important factor in the development of 58 inflammatory bowel disease, as it has been shown that the number of bacteria 59 attached to the intestinal tract is higher in IBD that in those of the normal population 4, 60 5 . 61
62
The etiology of IBD remains unresolved, however the persistent inflammation seen in 63 IBD may be a result of enhanced immunological response to natural constituents of 64 the gut or an autoimmune dysregulation or imbalance 6 . Despite these proposedpostconfluence 14 . They are also able to form microvilli and express small intestinal 100 like characteristics both biochemically and morphologically, including high P-101 glycoprotein expression 15, 16 . The RKO colorectal carcinoma cell line has virtually no 102 detectable P-gp activity and minimal BCRP activity, as shown from this study, and 103 previously 17 , while MCF-7 which is an oestrogen receptor positive, tumour derived 104 breast cancer cell model 18 , that also shows no functional expression of P-gp, but 105 does have high BCRP expression 19 . 106
Six bacterial species were used for this project, from Gram negative rod shaped 107 and Pseudomonas aeruginosa (NCTC 7244)) were inoculated onto agar plates and 147 incubated for 48 hours at 37°C. Clostridium sporogenes (NCTC 533) was also 148 inoculated onto agar plates and grown in anaerobic conditions for 72 hours. 149
150
BacLight Green preparation 151
Preliminary studies were conducted on BacLight Green stain (dissolved in DMSO to 152 form 1 mM stock concentrations) to identify its potential to inhibit bacterial growth. 153
Colonies of bacteria were scraped from agar plates and suspended in cold sterile 154 PBS. The bacteria were then centrifuged at 3000 g for 10 minutes. Resuspending the 155 pellet in 2x500µL cold PBS, 8µL of a 100µM BacLight Green solution in DMSO was 156 added to one tube for each of the bacteria to give a final dye concentration of 1.60growth retardation has occurred either with colony counts or general growth 163
characteristics. 164
Fluorescence method 165
A 96 well fluorescence plate reader (Fluostar Optima) from BMG LabTech 166 (Mornington, Victoria, Australia) was used to detect fluorescent bacteria in black 96 167 well plates. A 485 nm Excitation filter and 520nm Emission filter were used for 168 detection using both top excitation and emission. 169
170
Determining a rapid cell count 171
In order to count the number of colony forming units on the same day as the 172 fluorescence study, standard curves were developed for each of the 6 bacteria. 173
Firstly a test was done to ensure that the absorbance measurement was not altered 174 by adding the fluorescent dye to the bacteria. Stained and unstained bacterial 175 suspensions in PBS were serially diluted in 96 well plates from stock, to 1/256 th of 176 stock. Absorbance measurement was carried on these samples at 415nm 177 wavelength using a Tecan Sunrise 96 well plate reader using the Magellan 3 178 software for Windows 2000. There was no significant difference between the 179 absorbance for the bacterial suspensions with or without BacGreen Light staining. 180
Samples from each well of bacteria was diluted 1000 fold in PBS and spread over 181 4.7cm agar plates and allowed to grow for up to 48 hours. Dilutions of bacteria that 182 showed between 40 and 1000 colony forming units per plate were used for 183 generation of standard curves. After incubation, the colonies on each of the plates 184 were counted using a Chemilmager™ 4400 from AlphaInnotech (Cell Biosciences, 185
Santa Clara, CA, USA) with the assistance of the colony counting module with the 186 cell count and provided a formula to estimate cell count from absorbance to be 188 determined for all individual bacterial species ensuring equivalent bacterial addition 189 to the human cell lines. In addition, previous studies had already shown 'growth medium' (high glucose DMEM with 25 mM Hepes (pH 7.4), 2 mM glutamine, 197 1 mM non-essential amino acids, 100 U/ml penicillin-streptomycin and 10% fetal calf 198 serum (FCS)) in a 37ºC incubator with 5% CO 2 . 
P-gp and other transport inhibition/enhancement: 210
In studies where inhibition of P-gp, MRP1, MRP2 or BCRP were performed in 211 conjunction with known substrates, cells were pre-incubated in HBSS containing the 212 inhibitors for 30 min before initiation of the study. The P-gp inhibitors included 4 µM 213 PSC-833 and 4 µM GF120918 (although this P-gp inhibitor is also known to inhibit 214 BCRP). Fumitremorgin C at 10 µM was used as a potent BCRP inhibitor, and 215
Glyburide (200 µM) was used as broad MRP and ABCA1 inhibitor, although was 216 subsequently discovered to inhibit P-gp also. The general MRP inhibitors 500 µM 217 probenecid or for MRP1, MK571 at 25 µM were also used, to provide comparative 218
non-Pgp efflux inhibition data. 219
In studies where induction of active efflux proteins was attempted, cells were 220 incubated with 20 µM rifampicin, 10 µM β-estradiol, 50 µM carbamazepine or 10 µM 221 progesterone for 48 hours (Progesterone is a known P-gp inhibitor, however other 222 research suggested that it could induce BCRP and P-gp over the long term) 21, 22 . 223
Our data suggested that the only significant outcome of 48h pre-incubation with 224 progesterone was binding of progesterone to P-gp that was not washed off with cold 225 PBS, with little evidence of induction via western blotting (results not shown). 226
227
Confirmation of P-gp induction 228
To confirm that P-gp inducers such as rifampicin, methylprednisolone or 229 progesterone increased the expression of active efflux proteins, western blotting was 230 performed to measure protein levels. MP -30°C cooled digital camera. AlphaEase software was used to generate 308 integrated density values of the proteins detected using chemiluminescence. 309
Bacterial attachment study 310
Prior to initiation of this study, fresh batches of bacterial broths were prepared and 311 then plated to ensure no contamination has occurred. A number of these colonieswere scraped from the culture plates, suspended in PBS and washed. BacLight 313
Green was added to each of the bacterial solutions to produce a concentration of 800 314 nM and incubated for 45 minutes. After incubation, solution was centrifuged at 12000 315 rpm for 6 minutes, washed 3 times with PBS and made up with PBS to a final volume 316 of 1mL. 100µL of each sample was then diluted in 2 fold steps along a row of a 96 317 multi-well plate and absorbance measured using a Tecan sunrise plate reader with a 318 415 nm filter. From the readings, concentrations of each bacterial species could be 319 calculated. 320 321 PSC 833 and GF 120918 inhibit P-gp function by blocking the ATPase pump in a 322 competitive manner, therefore these inhibitors must be present at all times during the 323 bacterial attachment study [27] [28] [29] . Previous studies from our laboratory have shown 324 both of these P-gp inhibitors to be very effective at the concentrations used in this 325 study to block P-gp activity in the same Caco2 cell line used here [30] [31] [32] . The 326 concentration of each of the bacteria calculated from the standard curves was then 327 used to produce solutions with a final bacterial concentration of 10 7 CFU/100µL made 328 up in DMEM containing either 4 µM of GF 120918 or PSC 833. Likewise, studies 329 conducted with 25 µM MK571, 500 µM probenecid, 5 µM fumitremorgen C, 100 µM 330 genestein, 50 µM quercetin and 200 µM glyburide were prepared in the same way. 331 332 Unlike our proposed inhibitors of active efflux proteins, the agents we considered as 333 potential inducers needed 48 to 72 hours preincubation. When rifampicin, 334 carbamazepine, progesterone or β-estradiol were used our confluent human cell 335 cultures needed to be pre-incubated with these inducers 48 hours before the 336 commencement of the bacterial attachment study as they had been shown in other 337 studies, with different cells lines to increase P-gp function by enhancing itsexpression 33, 34 . However, our western blot results were not conclusive in illustrating 339 increased P-gp expression (results not shown). Nevertheless, cells preincubated with 340 these agents we washed free of the drugs before initiating our hour bacterial 341 adhesion studies to reduce the possibility that some of the potential inducing agents 342 could have also had short term functional blocking ability. Some of the inducers of P-343 gp protein do so by blocking function of the protein, which encourages cells to 344 upregulate expression of P-gp to compensate for the loss of existing function 35, 36 . well, and each assay was done with quadruplicate individual wells at each time point. 365
Test to confirm that P-gp inhibitors do not affect growth of bacteria 366
To exclude the possibility of the P-gp inhibitors having a direct effect on the growth of 367 the bacteria, parallel studies were conducted where co-incubation with the active 368 efflux inhibitors was followed by culturing on nutrient agar plates and placing at 37°C 
Results
385
Individual efflux proteins were determined by Western blot analysis. Of the three cell 386 lines examined, Caco2 cells proved to be the only one with significant quantities of P-387 gp (ABCB1) expressed (Figure 1 (Figures 2 and 3) . Depending on thebacterial species, adhesion started to reach a plateau by 3 hours. Examples of 410 Escherichia coli (Figure 2) and Staphylococcus aureus are shown here (Figure 3) , 411 however the general trend was similar for all six species of bacteria examined. 412
Bacterial
The Rhodamine 123 bidirectional transport study shown here illustrates the 421 effectiveness of PSC-833 at blocking P-gp function as evidenced by the increased 422 apical to basolateral transport and decreased bacterial to apical transport of the 423 known P-gp substrate rhodamine 123 34 . Our previous studies with GF120918 also 424 show similar effectivenesss of GF120918 in Caco-2 cells at blocking functional P-gp 425 activity 16, 30 . 426
It was evident that an increasing bacterial load occurred over a 3 to 4 hour time 427 course. However, RKO and MCF7 cells, with little to no P-gp expression, had much 428 greater absolute fluorescence than the Caco2 cells (Figures 2 and 3) . When P-gp 429 was blocked with GF120918, as shown in figures 2 and 3, this allowed bacterial 430 attachment in Caco2 cells to start increasing to that of the other cell lines. Very 431 similar results were obtained using PSC833, another common P-gp inhibitor, which is 432 equally effective towards P-gp without affecting BCRP activity (Table 1) . Rifampicin 433 pre-incubation was not significantly effective at reducing Eschericia coli associatedreduced binding to Caco2 cells with rifampicin pre-exposed cells (Figure 3 , Table 1) . 436
Minimal increases in P-gp expression shown in Figure 1 , and no change in 437 bidirectional Rh123 transport (Figure 4 ) indicate that little change had occurred with 438 P-gp expression, so it was not surprising that irrespective of Caco2 exposure to 439 rifampicin, bacterial adhesion results were similar in the majority of cases. 440
441
Time course experiments were repeated with numerous co-incubated active efflux 442 inhibitors to further the hypothesis that P-gp was responsible for altering bacterial 443 adhesion. For clarity the 180 min data is shown due to the trend in adhesion 444 differences being similar for all time points. MK571 is a specific MRP1 inhibitor and it 445 did have a small effect on increasing accumulation of Escherichia coli and 446
Staphylococcus aureus, but did not affect Salmonella typhimurium or Clostridium 447
sporogenes in Caco2 cells (Table 1) . Probenecid is a multiple MRP inhibitor, yet had 448 no effect at all on any bacterial adhesion. Quercetin and genestein are also thought 449 to modify the MRP family of transporters 38, 39 , yet they also had no effect on any 450 bacterial adhesion of Caco2 cells here (Table 1) . As GF120918 has the potential to 451 block BCRP in addition to P-gp, a potent specific BCRP blocking agent 452 (Fumitremorgin C) 40 was tested at concentrations known to be effective against 453
BCRP in vitro
41 to elucidate the mechanisms of GF120918. This agent had no effect 454 on bacterial binding to Caco2 cells (Table 1 ), although their BCRP protein level is low 455 (Figure 1) . Importantly, it did have some effect on bacteria remaining associated with 456 MCF7 cultures (Table 2) , which have much higher expression of BCRP (Figure 1) , 457 but this only resulted in 30 to 60% increases in bacterial loading, while blocking the 458 activity of P-gp increased some of the bacterial association with Caco2 cells up to 3 459 fold higher.
Progesterone was used for 48 hour pre-incubations of the human cell lines as one 461 report stated that long term exposure to 10 µM progesterone could increase BCRP in 462 some oestrogen sensitive cells lines 22 and P-gp levels in other cell lines by 2 fold 21,
463
42 . However, progesterone is one of the few potent P-gp blocking agent that is not 464 transported by P-gp, and thus, is likely to block using mechanisms that do not involve 465 the active site, and may persist for some time 43 , and although the Caco2 cells in this 466 study were washed 3 times in cold PBS before initiating bacterial adhesion, it is likely 467 that much of the progesterone bound to the P-gp receptor remained attached and 468 therefore continued to act as a blocking agent while adhesion studies were 469 conducted, and this was the likely reason significant increases in bacterial adhesion 470 were observed in this particular section of the study (Table 1 ). The RKO cell line, 471 which had almost no P-gp expression, also had much higher total fluorescence, and 472 thereby total bacterial association with the RKO cells compared to Caco-2 cells, 473 mirroring the relative P-gp expression differences between these cells (Figures 2 and  474 3). Rifampicin is well known as a P-gp inducer 44 to apical transport after preincubation of rifampicin, which would have been expected 492 if P-gp was working with greater effectiveness on this P-gp substrate (Figure 4) . 493
However, unlike functional blocking assays where drugs will have a relatively specific 494 targets such as P-gp, when trying to induce expression using various drugs, it is 495 likely that many parameters are being changed beyond induction of P-gp alone, 496 which makes examination of reduced binding of bacteria as a response of P-gp more 497 challenging to prove into the future, than the evidence of increased binding through 498 functional P-gp blockage which is a much clearer conclusion from the data of this 499 study. 500 501 502
Discussion
503
This study has shown compelling evidence that P-gp expression, and possibly BCRP 504 expression to some degree, has a significant ability to prevent close association of 505 bacteria with human gastrointestinal cells. This is the first stage of pathogenic 506 bacterial cellular invasion by creating an environment from which to cause an 507 infection, and thus low P-gp expression may allow an increased risk of pathological 508 can take the form of bacterial cell wall components (polysaccharides, glycoproteins, 516 glycolipid), cell capsules or fimbriae 2, 47 . It is here that we would expect any 517 interactions between P-gp and bacterial adhesion to occur. 518
519
Our results showed the P-gp blocking agents PSC 833, GF 120918, progesterone 520 and to a limited extent, glyburide, all increase bacterial attachment to Caco2 cells, 521 which indicates the involvement of P-gp in limiting the attachment of bacteria to these 522 cells. We have used PSC-833 and GF120918 in many previous bidirectional drug 523 transport studies with Caco2 cell monolayers and find them to both give excellent P-524 gp blocking ability at the concentrations used in this study. In addition, rhodamine 525 123 bidirectional studies were repeated in this study to show the effectiveness of 526
Glyburide was initially used in other labs as an ABCA1 inhibitor 48 , however, it was 528 clear from other publications that this agent has moderate P-gp blocking ability as 529 well 49 . Thus, although glyburide was not as potent as PSC-833, or GF120918 in this 530 study at increasing bacterial attachment, this would be keeping within its likely 531 potency range against P-gp. 532
533
Some of the bacterial species, such as Staphylococus aureus were able to increase 534 their foothold on Caco2 cells as active P-gp was depleted to a far greater extent than 535 other bacteria. Staphylococcus aureus incubation resulted in much higher cell 536 fluorescent counts compared to the other five examined, suggesting better binding to 537 the human cells, and P-gp blockage also produced the greatest fold increases for this 538 bacteria as well as other bacteria known to invade the gastrointestinal environment, 539 such as Clostridium sporogenes and Salmonella typhimurium, especially when 540 compared to the more pulmonary infective agents such as Pseudomonas and 541
Klebsiella. Interestingly, Salmonella typhimurium has been shown previously to 542 interact with P-gp, downregulating its expression 50 , which has been suggested can 543 increase its own infectiveness. Other bacteria used in this study, such as E.coli W 544 are not overtly pathogenic 51 , and this may have explained why the fold increase of 545 bacterial fluorescence was not up to the level of the other gastrointestinal infective 546 bacteria. The use of more virulent E.coli bacteria in more stringent PC3 lab facilities 547 may assist in providing answers in this area. 548
However, using a virulent strain of Salmonella typhimurium, a research group 549 recently showed canine MDCKII cells overexpressing human P-gp to internalise less 550 than 20% of the bacteria compared to the same MDCKII cell line not overexpressing 551 P-glycoprotein 50 . Their data matches the response of Salmonella typhimurium in this 552 current study using human Caco2 cells very closely. In their study all bacteriaexternal to the MDCKII cells were killed, and the internalised cells were extracted and 554 plated for colony forming units to be counted, showing an 80% reduction in 555 internalised Salmonella. In this current study fluorescence associated with the cells 556 was determined simply using a 96 well plate reader. Remarkably, their study and 557 these current results come to the same conclusion, being that the expression of 558 functional human P-gp will limit close association with bacteria capable of inducing 559 potential infections. 560
561
Other human cell lines that expressed much lower amounts of P-gp, or expressed 562 other efflux proteins indicated that the influence of other efflux proteins, such as 563 BCRP, may have a small role to play, but it was P-gp that appeared to limit the 564 bacterial adhesion when comparing the combination of cells lines examined and 565 inhibitors used. For example, in the MCF7 cell line, which has BCRP as its efflux 566 protein of greatest expression, the P-gp inhibitor PSC-833 had no effect, which was 567 not surprising given the lack of P-gp in the cell line, while GF120918 was more 568 effective, but not to the same level in Caco-2 cells. In these cells GF120918 would be 569 blocking P-gp to a larger extent than BCRP, as Caco2 cells were shown here to have 570 much less BCRP than the MCF7 cell line. In addition, the BCRP specific inhibitor 571 It is known that some 594 polysaccharides and proteins are P-gp substrates 52, 53 , which forms the basis of this 595 study's proposal that bacterial adhesion factors that are comprised of these materials 596 may interact with P-gp and in turn the attachment process may be affected due to 597 this interaction. P-gp is able to recognize foreign substrates, in this case the bacterial 598 attachment factors, preventing the bacteria from attaching by dislodging these factors 599 from the cell surface. 600
601
A recent clinical study showed decreased P-gp protein expression in the colon of 602 patients, and the lower the expression, the greater the clinical inflammation from 603
Ulcerative colitis. Their conclusion was that IL-8 and other cytokines had reduced the 604
MDR1 protein
13 . Our data in this current study conforms with this clinical experiment,except that our data would suggest that the clinical inflammation in IBD (similar to 606 that seen in previous mdr1a knockout mice studies 7 ) may be a result of the lower P-607 gp expression, rather than the low P-gp expression coming from the increased 608 clinical inflammation 13 . Thus, time course studies that follow when low expression 609 has occurred would be the next step to confirming this hypothesis. 610
611
The data in this study supports the concept that P-gp not only is protective of 612 xenotoxic compounds, but also protects from the bacteria themselves getting close 613 enough to initiate a cascade of toxic or inflammatory events that leads to clinical 614 diseases such as ulcerative colitis. It has been suggested that in the gastrointestinal 615 tract if a person has a homozygous CC polymorphism at position 3435 of the ABCB1 616 (MDR1) code this would provide up to 2 fold greater defence against xenobiotics, and 617 that this is the rationale behind the TT homozygous allele only representing 6% of 618 the African population 54, 55 . They are thought to have increased resistance to 619 gastrointestinal illness, and our data would support this resistance being a 620 combination of allowing bacteria to be flushed through the gut more rapidly and 621 having delayed attachment that would otherwise lead to subsequent gastrointestinal 622 damage, in addition to xenobiotic compound efflux from foods consumed in their diet. 623 624
Conclusions:
625
In conjunction with a recent publication examining Salmonella typhimurium 626 interactions with P-gp expression, and the ability of P-gp to block uptake of 627 Salmonella in MDCK cells 50 , this current study shows that functional P-gp reduces 628 adhesion of many species of bacteria directly to human cells endogenously 629 expressing this efflux protein, suggesting a mechanism to explain increased intestinalcolitis in mdr1(-/-) knock-out mice from studies conducted over a decade ago 7 , and 631 providing potential insights into our understanding of gastrointestinal disorders 632 initiated by bacterial adhesion in humans. 633
The next step in the examination of this P-gp and bacterial adhesion association will 634 be to examine key adhesion molecules and their interaction with P-gp directly, with 635 bidirectional transport studies needed to elucidate the transporter affinity of these 636 peptides for active efflux transport. In addition, with current data showing low P-gp 637 expression in patients with active inflammatory bowel disease 13 , time course studies 638 should be conducted to examine whether P-gp expression in these patients is lower 639 before or after the induction of an acute attack. This information would assist in 640 determining the causative nature of acute attacks, and whether P-gp is acting to 641 defend the colon from bacterial induced inflammation or not. 642
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